• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肺曲霉病的预后因素:来自日本的 264 例回顾性队列研究。

Prognostic factors of chronic pulmonary aspergillosis: A retrospective cohort of 264 patients from Japan.

机构信息

Center for Pulmonary Diseases, Department of Respiratory Medicine, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.

出版信息

PLoS One. 2021 Apr 1;16(4):e0249455. doi: 10.1371/journal.pone.0249455. eCollection 2021.

DOI:10.1371/journal.pone.0249455
PMID:33793645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016288/
Abstract

BACKGROUND

Chronic pulmonary aspergillosis (CPA) develops in various underlying pulmonary conditions. There is scarce data evaluating interstitial lung disease (ILD)/abnormalities (ILA) as such conditions, and it has not been explored much whether non-tuberculous mycobacterial pulmonary disease (NTM-PD) is a prognostic factor for mortality in CPA patients. Few reports had investigated prognostic factors of CPA including underlying pulmonary conditions.

OBJECTIVES

To explore prognostic factors of CPA including pulmonary conditions.

METHODS

We conducted a retrospective cohort study of 264 CPA patients from a center for pulmonary aspergillosis in Japan.

RESULTS

Survival rates were 78.7%, 61.0%, and 47.4% at 1, 3, and 5 years, respectively. Of 264 patients, 53 (20.1%) and 87 (33.1%) were complicated with ILA and NTM-PD. Several independent prognostic factors were identified by multivariate Cox proportional analysis: ILA (HR 1.76, 95%CI 1.06-2.92, p = 0.029), age (1.05, 1.02-1.08, p<0.001), male sex (2.48, 1.34-4.59, p = 0.004), body mass index of <18.5 kg/m2 (1,87, 1.20-2.90, p = 0.005), presence of aspergilloma (1.59, 1.04-2.45, p = 0.033), and lower serum albumin (0.56, 0.38-0.83, p = 0.004). NTM-PD was not associated with higher mortality (0.85, 0.52-1.38, p = 0.51).

CONCLUSIONS

The poor prognosis of CPA and several prognostic factors were revealed. Early diagnosis and intervention is required with reference to such factors.

摘要

背景

慢性肺曲霉病(CPA)可在各种基础肺部疾病中发展。关于特发性肺间质纤维化/异常(ILA)等疾病的数据很少,而非结核分枝杆菌肺病(NTM-PD)是否是 CPA 患者死亡率的预后因素也尚未得到充分探讨。很少有报告探讨包括基础肺部疾病在内的 CPA 的预后因素。

目的

探讨包括肺部疾病在内的 CPA 的预后因素。

方法

我们对来自日本肺曲霉病中心的 264 例 CPA 患者进行了回顾性队列研究。

结果

1、3、5 年的生存率分别为 78.7%、61.0%和 47.4%。在 264 例患者中,53 例(20.1%)和 87 例(33.1%)并发 ILA 和 NTM-PD。多变量 Cox 比例分析确定了几个独立的预后因素:ILA(HR 1.76,95%CI 1.06-2.92,p=0.029)、年龄(1.05,1.02-1.08,p<0.001)、男性(2.48,1.34-4.59,p=0.004)、BMI<18.5kg/m2(1.87,1.20-2.90,p=0.005)、曲霉球存在(1.59,1.04-2.45,p=0.033)和血清白蛋白水平较低(0.56,0.38-0.83,p=0.004)。NTM-PD 与更高的死亡率无关(0.85,0.52-1.38,p=0.51)。

结论

揭示了 CPA 的不良预后和几个预后因素。需要根据这些因素进行早期诊断和干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b09/8016288/d2eac8404b94/pone.0249455.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b09/8016288/08a1866d4c83/pone.0249455.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b09/8016288/e3eeb2dc5217/pone.0249455.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b09/8016288/d2eac8404b94/pone.0249455.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b09/8016288/08a1866d4c83/pone.0249455.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b09/8016288/e3eeb2dc5217/pone.0249455.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b09/8016288/d2eac8404b94/pone.0249455.g003.jpg

相似文献

1
Prognostic factors of chronic pulmonary aspergillosis: A retrospective cohort of 264 patients from Japan.慢性肺曲霉病的预后因素:来自日本的 264 例回顾性队列研究。
PLoS One. 2021 Apr 1;16(4):e0249455. doi: 10.1371/journal.pone.0249455. eCollection 2021.
2
Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease.肺部非结核分枝杆菌病患者慢性肺曲霉病的预后
Respir Investig. 2018 Jul;56(4):326-331. doi: 10.1016/j.resinv.2018.04.002. Epub 2018 May 11.
3
The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.非结核分枝杆菌患者发生慢性肺曲霉病的危险因素以及合并非结核分枝杆菌感染的慢性肺曲霉病患者的临床特征和转归。
Med Mycol. 2016 Feb;54(2):120-7. doi: 10.1093/mmy/myv093. Epub 2015 Nov 3.
4
Predictors of mortality in chronic pulmonary aspergillosis.慢性肺曲霉病患者的死亡率预测因素。
Eur Respir J. 2017 Feb 8;49(2). doi: 10.1183/13993003.01062-2016. Print 2017 Feb.
5
Clinical Impact of Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Pulmonary Disease and Role of Computed Tomography in the Diagnosis.非结核分枝杆菌肺病患者中慢性肺部曲霉菌病的临床影响及计算机断层扫描在诊断中的作用。
Intern Med. 2023 Nov 15;62(22):3291-3298. doi: 10.2169/internalmedicine.0836-22. Epub 2023 Mar 15.
6
Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病患者发生慢性肺曲霉病的危险因素。
PLoS One. 2017 Nov 30;12(11):e0188716. doi: 10.1371/journal.pone.0188716. eCollection 2017.
7
Patient background and prognosis of chronic pulmonary aspergillosis in fibrosing interstitial lung disease.特发性肺纤维化患者中慢性肺曲霉病的背景和预后。
Medicine (Baltimore). 2022 Aug 12;101(32):e29936. doi: 10.1097/MD.0000000000029936.
8
Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease.鸟分枝杆菌复合群肺病患者发生慢性肺曲霉病的风险分层
J Infect Chemother. 2018 Aug;24(8):654-659. doi: 10.1016/j.jiac.2018.04.002. Epub 2018 Apr 26.
9
[Clinical analysis of non-tuberculous mycobacteriosis cases complicated with pulmonary aspergillosis].非结核分枝杆菌病合并肺曲霉病病例的临床分析
Kekkaku. 2011 Sep;86(9):781-5.
10
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.伏立康唑治疗慢性肺曲霉病的疗效和安全性:日本的经验。
Infection. 2012 Dec;40(6):661-7. doi: 10.1007/s15010-012-0322-x. Epub 2012 Sep 7.

引用本文的文献

1
Clinical characteristics and risk factors analysis of allergic bronchopulmonary aspergillosis combined with bronchiectasis.变应性支气管肺曲霉病合并支气管扩张的临床特征及危险因素分析
Front Med (Lausanne). 2025 May 23;12:1557241. doi: 10.3389/fmed.2025.1557241. eCollection 2025.
2
Identification of prognostic factors of chronic pulmonary aspergillosis: a retrospective cohort of 106 patients.慢性肺曲霉病预后因素的识别:一项针对106例患者的回顾性队列研究。
J Thorac Dis. 2024 Nov 30;16(11):7310-7319. doi: 10.21037/jtd-24-831. Epub 2024 Nov 14.
3
Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges.

本文引用的文献

1
Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.1445例非结核分枝杆菌肺病患者长期死亡率的预后因素:一项15年随访研究
Eur Respir J. 2020 Jan 2;55(1). doi: 10.1183/13993003.00798-2019. Print 2020 Jan.
2
Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study.西班牙一家三级护理中心的慢性肺曲霉病:一项回顾性观察研究。
Mycoses. 2019 Sep;62(9):765-772. doi: 10.1111/myc.12950. Epub 2019 Jun 25.
3
Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers.
慢性肺曲霉病:关于流行病学、治疗及未解决挑战的全面见解
Ther Adv Infect Dis. 2024 Jun 18;11:20499361241253751. doi: 10.1177/20499361241253751. eCollection 2024 Jan-Dec.
4
Loss to follow-up associated factors in patients with chronic pulmonary aspergillosis and its impact on the disease prognosis.慢性肺曲霉病患者失访的相关因素及其对疾病预后的影响。
Front Public Health. 2022 Dec 13;10:1026855. doi: 10.3389/fpubh.2022.1026855. eCollection 2022.
5
Clinical Features, Diagnostic Test Performance, and Prognosis in Different Subtypes of Chronic Pulmonary Aspergillosis.慢性肺曲霉病不同亚型的临床特征、诊断检查表现及预后
Front Med (Lausanne). 2022 Feb 11;9:811807. doi: 10.3389/fmed.2022.811807. eCollection 2022.
6
Chronic Pulmonary Aspergillosis: Disease Severity Using Image Analysis and Correlation with Systemic Proinflammation and Predictors of Clinical Outcome.慢性肺曲霉病:利用图像分析评估疾病严重程度及其与全身炎症的相关性和临床结局预测因素
J Fungi (Basel). 2021 Oct 7;7(10):842. doi: 10.3390/jof7100842.
监测慢性肺曲霉病的治疗反应:临床、肺功能和免疫学标志物的作用。
Clin Microbiol Infect. 2019 Sep;25(9):1157.e1-1157.e7. doi: 10.1016/j.cmi.2019.01.007. Epub 2019 Jan 25.
4
Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease.鸟分枝杆菌复合群肺病患者发生慢性肺曲霉病的风险分层
J Infect Chemother. 2018 Aug;24(8):654-659. doi: 10.1016/j.jiac.2018.04.002. Epub 2018 Apr 26.
5
Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.206 例慢性肺曲霉病患者的 12 个月临床转归。
PLoS One. 2018 Apr 10;13(4):e0193732. doi: 10.1371/journal.pone.0193732. eCollection 2018.
6
Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病患者发生慢性肺曲霉病的危险因素。
PLoS One. 2017 Nov 30;12(11):e0188716. doi: 10.1371/journal.pone.0188716. eCollection 2017.
7
Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013.2001 - 2013年加拿大安大略省与非结核分枝杆菌相关的肺部死亡病例
Emerg Infect Dis. 2017 Mar;23(3):468-476. doi: 10.3201/eid2303.161927.
8
Predictors of mortality in chronic pulmonary aspergillosis.慢性肺曲霉病患者的死亡率预测因素。
Eur Respir J. 2017 Feb 8;49(2). doi: 10.1183/13993003.01062-2016. Print 2017 Feb.
9
A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.一项为期10年的研究揭示了慢性肺曲霉病“半侵袭性”特征的临床和实验室证据。
Emerg Microbes Infect. 2016 Apr 20;5(4):e37. doi: 10.1038/emi.2016.31.
10
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.慢性肺曲霉病:诊断和管理的原理和临床指南。
Eur Respir J. 2016 Jan;47(1):45-68. doi: 10.1183/13993003.00583-2015.